European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
Concerns over falling vaccination coverage within National Immunisation Programme The percentage of children vaccinated within the National Immunisation Programme (NIP) has fallen for the second year in a row, according to the 2022 report ‘Vaccination Coverage and Annual Report of the Dutch National Immunisation Programme'. RIVM is concerned about this decline.
Breast implants can cause health problems even five years or more after placement Over the past 5 years, the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI) has received 977 reports of health problems related to breast implants. An analysis by RIVM has shown that 39% of the reported health problems started 5 or more years after the implant’s placement.
No indication that investigated mesh implants used to treat pelvic organ prolapse are unsafe RIVM has conducted a laboratory study into six mesh implants from different manufacturers used in the Netherlands in 2018. The study revealed no indication that these products are unsafe for patients.
Safe recycling of textiles possible, but still in its infancy Textiles are produced using chemicals. Although many hazardous chemicals may no longer be used in textile production, they may still be present in donations of old clothing. RIVM has conducted a study into the safety of recycled textiles.
RSV summer peak possibly caused by declining antibodies during COVID-19 pandemic RSV, or respiratory syncytial virus, is a common virus that causes cold symptoms. In particularly, young children and vulnerable older people are more likely to become seriously ill if they get it.
Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
High rates of RSV in children over the summer, and a late flu epidemic in the 2021-2022 season Hospitals reported an unusually large number of children presenting with RSV over the summer of 2021. The number of positive coronavirus tests rapidly increased after the summer of 2021.
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..